Fundraising Fox

Marianne Uteng

Investor

Managing Director at Novartis Venture Fund

Basel, Switzerland

Writes $5M – $10M checks · typically $7.5M

About

Marianne Uteng, PhD, is a Managing Director at Novartis Venture Fund in Basel. She previously worked in Novartis Global Drug Development and its Pre-Clinical Safety Department, leading teams on safety assessments for early and late-stage programs, and supported Novartis BD&L Search & Evaluation while building collaborations with biotech companies and academia. She holds an MSc in Biochemistry from the University of Oslo and a PhD in Molecular Biology, Cell Biology & Biophysics from a joint EMBL–University of Oslo program.

Invests in

Biotech

Experience

  1. NovartisManaging Director at Novartis Venture Fundcurrent2023 — presentBasel, Switzerland
  2. AstronauTxMember Board of Directorscurrent2023 — present
  3. Tagworks PharmaceuticalsMember Board of Directorscurrent2023 — presentNetherlands
  4. Epsilogen LtdBoard Directorcurrent2022 — presentUnited Kingdom
  5. CatalYm GmbHBoard Observercurrent2022 — presentMunich, Bavaria, Germany
  6. CatalYm GmbHBoard Director2021 — 2022Germany
  7. Amphista Therapeutics LimitedBoard Observercurrent2021 — presentGreater London, England, United Kingdom
  8. Rappta TherapeuticsBoard Observercurrent2020 — presentHelsinki, Uusimaa, Finland

Education

  1. European Molecular Biology Laboratory (EMBL)PhD, Cell Biology & Biophysics2003 — 2008
  2. University of OsloMaster's degree, Biochemistry1997 — 2003

Skills & more

Venture CapitalBiomarkers16Biotechnology5Biomarker Discovery3Clinical Development3Clinical Trials3Drug Development2Drug Discovery4In Vitro3Biochemistry8Lifesciences10Molecular Biology14
+10 moreNMROncologyPeptidesPharmaceutical IndustryStructure ElucidationToxicologyCellLife SciencesLaboratoryCell Biology

From Marianne's professional profile.

Same school

Shared employers

Colleagues at Novartis Venture Fund